How to diagnose axial spondyloarthritis early
Top Cited Papers
Open Access
- 1 May 2004
- journal article
- other
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 63 (5), 535-543
- https://doi.org/10.1136/ard.2003.011247
Abstract
Background: Chronic low back pain (LBP), the leading symptom of ankylosing spondylitis (AS) and undifferentiated axial spondyloarthritis (SpA), precedes the development of radiographic sacroiliitis, sometimes by many years. Objective: To assign disease probabilities and to develop an algorithm to help in the early diagnosis of axial SpA. Methods: Axial SpA comprises AS and undifferentiated SpA with predominant axial involvement. Clinical features include inflammatory back pain (IBP), alternating buttock pain, enthesitis, arthritis, dactylitis, acute anterior uveitis, a positive family history, psoriasis, inflammatory bowel disease, and good response to NSAIDs. Associated laboratory findings include raised acute phase reactions, HLA-B27 association, and abnormalities on skeletal imaging. Sensitivities, specificities, and likelihood ratios (LRs) of these parameters were determined from published studies. A 5% prevalence of axial SpA among patients with chronic LBP was used. The probability of the presence of axial SpA, depending on the presence or absence of the above clinical features of SpA, was determined. A probability of ⩾90% was used to make a diagnosis of axial SpA. Results: The presence of inflammatory back pain features increased the probability of axial SpA from the background 5% prevalence to 14%. The presence of 2–3 SpA features was necessary to increase the probability of axial SpA to 90%. The highest LRs were obtained for HLA-B27 and MRI. Diagnostic algorithms to be used in daily practice were suggested. Conclusions: This approach can help clinicians to diagnose with a high degree of confidence axial SpA at an early stage in patients with IBP who lack radiographic sacroiliitis.Keywords
This publication has 58 references indexed in Scilit:
- Randomized double‐blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathyArthritis & Rheumatism, 2002
- HLA-B27 and spondyloarthropathy: value for early diagnosis?Journal of Medical Genetics, 1995
- Decision AnalysisNew England Journal of Medicine, 1987
- An epidemiological survey of the signs and symptoms of ankylosing spondylitisClinical Rheumatology, 1985
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984
- The value of quantitative sacroiliac scintigraphy in detection of sacroiliitisClinical Rheumatology, 1983
- Clinical symptoms and signs useful in the early diagnosis of ankylosing spondylitisClinical Rheumatology, 1983
- Use of the B27 test in the diagnosis of ankylosing spondylitis: a statistical evaluationArthritis & Rheumatism, 1981
- The Prevalence and Nature of Back Pain in an Industrial ComplexSpine, 1980
- In England NowThe Lancet, 1973